Human anti-opgl neutralizing antibodies as selective opgl pathway inhibitors

Monoclonal antibodies and hybridomas producing them that interact with osteoprotegerin ligand (OPGL) are provided. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are also provided. Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are further provided….

Source: http://www.freshpatents.com/-dt20120621ptan20120156725.php

chemical compound library chemical compound listing chemical listing

Related posts:

1. Cell-permeable peptide inhibitors of the jnk signal transduction pathway
2. A previous report possessed indicated that yeast sensitivity to Anti-GFP Antibodies
3. Therapeutic uses of inhibitors of rtp801
4. Nutrition Express Voluntarily Recalls Protein Supplements Because of Possible Health Risk
5. The radioimmunoassay described is a double antibody RIA using human Anti-MBP Antibody